NovaBridge Biosciences
Market Cap
$274.33M
P/E Ratio
-4.96
EPS
$-0.48
Dividend Yield
0.00%
52-Week Range
$0.83 — $6.79
Volume
1.85M
Avg Volume
864.60K
Beta
1.74
Get alerted when NBP hits your target price.
Free — enter your email to get started
P/E (TTM)
-4.96
Forward P/E
—
PEG Ratio
0.17
P/S (TTM)
0.00
P/B (TTM)
3.53
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.08%
ROA (TTM)
-0.18%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.01
Current Ratio
8.09
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.39%
EPS Growth (5Y)
-0.46%
Sales Growth (3Y)
-0.23%
Sales Growth (5Y)
+9.76%
EPS Est (This Year)
$-1.00
EPS Est (Next Year)
$-1.69
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.20
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
50.12M
Float
42.53M
Free Float %
84.86%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2020-01-17
Employees
32
CEO
Xi-Yong Fu
Index Membership
—
Website
https://www.i-mabbiopharma.com
NovaBridge Biosciences (NBP) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $274.33M, a P/E ratio of -4.96, NBP is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NBP against other stocks using dozens of fundamental and technical filters.
NovaBridge Biosciences (NBP) has a trailing twelve-month (TTM) P/E ratio of -4.96. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, NovaBridge Biosciences (NBP) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
NovaBridge Biosciences (NBP) has a market capitalization of $274.33 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.